A Calcium Blocking and Anticholinergic Agent (Terodiline) in the Treatment of Detrusor Hyperreflexia: A Placebo-Controlled, Cross-Over Trial.

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.50.10.1331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Efficacy and Safety of Propiverine in SCI-patients Suffering From Detrusor Hyperreflexia – A Double-Blind, Placebo-Controlled Clinical Trial

Spinal Cord
MedicineNeurologyRehabilitation
1999English

Medium-Dose Riboflavin as a Prophylactic Agent in Children With Migraine: A Preliminary Placebo-Controlled, Randomised, Double-Blind, Cross-Over Trial

Cephalalgia
MedicineNeurology
2010English

Selective Sacral Rootlet Neurectomy in the Treatment of Detrusor Hyperreflexia

Journal of Neurosurgery
SurgeryNeurology
1988English

Intravesical Electromotive Administration of Oxybutynin in Patients With Detrusor Hyperreflexia Unresponsive to Standard Anticholinergic Regimens

Journal of Urology
Urology
2001English

Homeopathy for Mental Fatigue: Lessons From a Randomized, Triple Blind, Placebo-Controlled Cross-Over Clinical Trial

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2012English

A Controlled Trial of Phenylbutazone, Oxyphenbutazone, and a Placebo in the Treatment of Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1961English

Buspirone Treatment of Cannabis Dependence: A Randomized, Placebo-Controlled Trial

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2015English

Retracted:Safety and Efficacy of Tramadol in the Treatment of Idiopathic Detrusor Overactivity: A Double-Blind, Placebo-Controlled, Randomized Study

British Journal of Clinical Pharmacology
Pharmacology
2006English

Treatment of Insomnia in Parkinson's Disease: A Controlled Trial of Eszopiclone and Placebo

Movement Disorders
Neurology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy